White House medical advisor Dr. Anthony Fauci said on ABC TV on Sunday that recipients of the Johnson & Johnson single-dose coronavirus vaccine should not worry about its lower effectiveness. He assessed this following the approval for use of an additional booster dose of the company’s vaccine.
The US Food and Drug Administration (FDA) advisory panel unanimously on Friday approved a booster dose of Johnson & Johnson (J&J) vaccine. He recommended that everyone aged 18 and older admit her two months after the first.
“I think they should feel good about it because FDA advisers, given the data, thought it very likely that it should be a two-dose vaccine,” said Fauci, who serves as director of the National Institute of Allergy and Infectious Diseases (NIAID).
“A favorable decision”
In his opinion, the panel’s decision is very favorable to those who received the J&J vaccine.
“The recommendation to all those who have received the J&J shot against COVID-19 to get an additional booster dose is a difference compared to the indications for the Moderna and Pfizer vaccines. They are currently only intended for Americans 65 years of age and older, and yes. so-called high-risk groups, ‘noted the ABC.
In his speech on Sunday, Fauci also considered the possibility of people vaccinated with a dose of J&J as boosting Pfizer or Moderna vaccines. He found this beneficial because then the level of obtained antibodies is much higher.
At the same time, however, a White House advisor warned that Moderna and Pfizer vaccines carry a slightly increased risk of myocarditis in young adults.
– It depends on who you are. For example, a woman of childbearing age who would have almost no problems with a possible undesirable problem of myocarditis – which is rare (…) with the use of an mRNA vaccine – could opt for this approach, he noted.
He added that a young man, who has a very, very rare risk of myocarditis, could nevertheless choose a dose of J&J as a booster vaccine. “
Main photo source: Johnson & Johnson